Global Health (NSE:MEDANTA) Shareholders Will Want The ROCE Trajectory To Continue
Dec 07
Have your own idea? Try our Stock Screener
Indian (NIFTY) Healthcare Sector Analysis
UpdatedDec 06, 2025
DataAggregated Company Financials
Companies315
- 7D-1.1%
- 3M-0.5%
- 1Y-1.8%
- YTD-3.6%
Over the last 7 days, the Healthcare industry has dropped 1.1%, driven by declines in Max Healthcare Institute and Sun Pharmaceutical Industries of 5.6% and 1.4%, respectively. Meanwhile, Wockhardt actually outperformed within the industry, gaining 10% in the last week. Over the last year, the industry has been flat overall. Looking forward, earnings are forecast to grow by 20% annually.
Sector Valuation and Performance
Has the Indian Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 07 Dec 2025 | ₹30.5t | ₹5.7t | ₹768.0b | 33.4x | 39.7x | 5.3x |
| Tue, 04 Nov 2025 | ₹30.9t | ₹5.5t | ₹739.5b | 35.1x | 41.8x | 5.6x |
| Thu, 02 Oct 2025 | ₹29.9t | ₹5.5t | ₹730.3b | 35.5x | 41x | 5.5x |
| Sat, 30 Aug 2025 | ₹29.9t | ₹5.5t | ₹730.0b | 35.1x | 41x | 5.5x |
| Mon, 28 Jul 2025 | ₹31.1t | ₹5.4t | ₹734.8b | 36.7x | 42.4x | 5.8x |
| Wed, 25 Jun 2025 | ₹29.2t | ₹5.3t | ₹728.5b | 35.6x | 40.1x | 5.5x |
| Fri, 23 May 2025 | ₹28.9t | ₹5.3t | ₹710.8b | 35x | 40.6x | 5.4x |
| Sun, 20 Apr 2025 | ₹28.1t | ₹5.2t | ₹680.2b | 34.2x | 41.4x | 5.4x |
| Tue, 18 Mar 2025 | ₹26.8t | ₹5.2t | ₹680.1b | 30.5x | 39.4x | 5.2x |
| Thu, 13 Feb 2025 | ₹27.6t | ₹5.2t | ₹670.6b | 34.8x | 41.1x | 5.3x |
| Sat, 11 Jan 2025 | ₹29.1t | ₹5.0t | ₹648.5b | 38.7x | 44.9x | 5.8x |
| Mon, 09 Dec 2024 | ₹29.2t | ₹5.0t | ₹643.1b | 39.1x | 45.4x | 5.8x |
| Wed, 06 Nov 2024 | ₹29.0t | ₹4.9t | ₹616.4b | 42.4x | 47x | 5.9x |
| Fri, 04 Oct 2024 | ₹29.0t | ₹4.9t | ₹605.3b | 42.6x | 47.9x | 6x |
| Sun, 01 Sep 2024 | ₹28.6t | ₹4.9t | ₹605.1b | 40.6x | 47.2x | 5.9x |
| Tue, 30 Jul 2024 | ₹26.5t | ₹4.7t | ₹560.5b | 39x | 47.3x | 5.6x |
| Thu, 27 Jun 2024 | ₹24.0t | ₹4.6t | ₹548.5b | 36.2x | 43.7x | 5.2x |
| Sat, 25 May 2024 | ₹23.2t | ₹4.7t | ₹551.2b | 34.7x | 42.1x | 4.9x |
| Mon, 22 Apr 2024 | ₹22.5t | ₹4.6t | ₹512.8b | 34.4x | 43.9x | 4.9x |
| Wed, 20 Mar 2024 | ₹22.0t | ₹4.6t | ₹512.5b | 32.6x | 42.8x | 4.8x |
| Fri, 16 Feb 2024 | ₹22.8t | ₹4.6t | ₹521.8b | 35.9x | 43.7x | 5x |
| Sun, 14 Jan 2024 | ₹21.3t | ₹4.4t | ₹477.0b | 37.5x | 44.7x | 4.8x |
| Tue, 12 Dec 2023 | ₹19.5t | ₹4.4t | ₹476.1b | 33.5x | 41x | 4.4x |
| Thu, 09 Nov 2023 | ₹18.6t | ₹4.3t | ₹462.3b | 32.7x | 40.1x | 4.3x |
| Sat, 07 Oct 2023 | ₹18.1t | ₹4.3t | ₹452.1b | 33x | 40x | 4.2x |
| Mon, 04 Sep 2023 | ₹17.7t | ₹4.2t | ₹450.7b | 31.5x | 39.3x | 4.2x |
| Wed, 02 Aug 2023 | ₹17.6t | ₹4.1t | ₹429.8b | 30.9x | 40.9x | 4.3x |
| Fri, 30 Jun 2023 | ₹16.3t | ₹4.1t | ₹425.6b | 28.4x | 38.3x | 4x |
| Sun, 28 May 2023 | ₹14.8t | ₹4.1t | ₹431.8b | 27.7x | 34.4x | 3.6x |
| Tue, 25 Apr 2023 | ₹13.8t | ₹3.9t | ₹373.0b | 26.5x | 37x | 3.6x |
| Thu, 23 Mar 2023 | ₹13.1t | ₹3.9t | ₹372.9b | 25x | 35.1x | 3.4x |
| Sat, 18 Feb 2023 | ₹13.4t | ₹3.9t | ₹373.3b | 25.6x | 36x | 3.5x |
| Mon, 16 Jan 2023 | ₹13.9t | ₹3.7t | ₹377.6b | 29.1x | 36.9x | 3.7x |
| Wed, 14 Dec 2022 | ₹14.1t | ₹3.7t | ₹377.3b | 29.2x | 37.3x | 3.8x |
Price to Earnings Ratio
37.3x
Current Industry PE
- Investors are relatively neutral on the Indian Healthcare industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 41.5x.
- The industry is trading close to its 3-year average PS ratio of 4.9x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have grown 27% per year over the last three years.
- Revenues for these companies have grown 15% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Indian Healthcare sector?
| IN Market | -0.83% | |
| Healthcare | -1.07% | |
| Life Sciences | 0.56% | |
| Pharma | -0.65% | |
| Biotech | -1.65% | |
| Healthtech | -1.98% | |
| Medical Equipment | -2.39% | |
| Healthcare Services | -3.27% | |
Industry PE
- Investors are most optimistic about the Biotech industry which is trading above its 3-year average PE ratio of 51.0x.
- Analysts are expecting annual earnings growth of 52.2%, which is higher than its past year's earnings decline of 53.0% per year.
- Investors are most pessimistic about the Pharma industry, which is trading close to its 3-year average of 36.8x.
Forecasted Growth
- Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 52% over the next 5 years.
- This is better than its past earnings decline of 53% per year.
- In contrast, the Pharma industry is expected to see its earnings grow by 16% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| WOCKPHARMA Wockhardt | ₹1.36k | 10.1% +₹20.3b | -2.1% | PS7.3x | |
| 500420 Torrent Pharmaceuticals | ₹3.78k | 1.6% +₹20.3b | 13.5% | PE59.8x | |
| ONESOURCE OneSource Specialty Pharma | ₹1.69k | 10.0% +₹17.6b | n/a | PE475x | |
| 500124 Dr. Reddy's Laboratories | ₹1.28k | 1.3% +₹14.1b | 1.7% | PE18.1x | |
| ANTHEM Anthem Biosciences | ₹654.45 | 3.1% +₹11.1b | n/a | PE71.2x |
